← Leaderboards
John G. Frelinger
University Of Rochester
$864,856
Attributed
$864,856
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $200.3K · FY2015–16$250K$187.5K$125K$62.5K$0
'15
'16
Funding mix
By agency
NIH$864,856 · 2
By mechanism
R01$497,607 · 1
R21$367,249 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- Nicholas Cohen$3,162,866
- Jacques Robert$11,910,879
- Andrew Phillip Wojtovich$6,718,082
- Edith M. Lord$14,314,079
- Michael C Keefer$52,523,093
Others in their field
Top investigators on “Adenocarcinoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$39,462,948
- Anirban Maitra · Johns Hopkins University$30,605,004
- Richard M Peek · Vanderbilt University Medical Center$23,246,493
- Gloria M. Petersen · Johns Hopkins University$21,134,227
- Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr$19,098,764
- Dean E. Brenner · University Of Michigan At Ann Arbor$18,393,816
Research focus
AdenocarcinomaCytokine ReceptorsAffinityAdverse EffectsAffectAntigen BindingAntitumor EffectBackBaseAntibodiesAntibody DiversityBiological Response ModifiersCancer TherapyCd8b1 GeneCd8-Positive T-LymphocytesCellsCellular ImmunityChemokineChimeric ProteinsColonComplexCxcl10 GeneCytokineCytotoxic
Grant awards (4)
Developing novel strategies for altering the cytokine microenvironment of tumors$200,318
R21 · FY2016 · CA · contact PI
Developing novel strategies for altering the cytokine microenvironment of tumors$166,931
R21 · FY2015 · CA · contact PI
TARGETED CTL MEDIATED IMMUNITY FOR PROSTATE CANCER$252,451
R01 · FY2001 · CA
TARGETED CTL MEDIATED IMMUNITY FOR PROSTATE CANCER$245,156
R01 · FY2000 · CA